Orin Hirschman 13D and 13G filings for Soleno Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-08-30 4:05 pm Purchase | 2023-06-06 | 13G | Soleno Therapeutics, Inc. SLNO | Orin Hirschman | 498,610 4.900% | 76,121 (+18.02%) | Filing |
| 2023-02-15 07:26 am Sale | 2022-12-31 | 13G | Soleno Therapeutics, Inc. SLNO | Orin Hirschman | 422,489 5.200% | -30,844 (-6.80%) | Filing |
| 2022-04-05 08:05 am Purchase | 2022-03-29 | 13G | Soleno Therapeutics, Inc. SLNO | Orin Hirschman | 453,333 5.700% | 453,333 (New Position) | Filing |